H Y Wu1, Y H Wu, Y Wang, M Chen, X Zhang, D Wang, Y Pan, L Li, D Liu, X M Dai, M X Dai. 1. Department of Endocrinology, Jingzhou First People's Hospital, Yangtze University, 8 Hang-kong street, Jingzhou, Hubei 434000, People's Republic of China. hongyan_wu2003@yahoo.com.cn
Abstract
BACKGROUND: Genetic variations in the engulfment and cell motility 1 (ELMO1) gene have recently been identified to be associated with nephropathy attributed to Type 2 diabetes mellitus (T2DM). Since T2DM-associated complications are proved to be more common among Asians than Western individuals, and Chinese people have a high incidence of diabetic nephropathy (DN), this study sought to analyze the association of ELMO1 gene polymorphisms with DN to probe into the effects of ELMO1 gene on susceptibility of DN in Chinese population. METHODS: We genotyped 6 polymorphism sites of ELMO1 gene in 200 unrelated Chinese subjects (123 T2DM with DN case subjects and 77 T2DM without DN control subjects). Genotyping was detected by a Sequenom MassARRAY genotyping system. RESULTS: The strongest associations in ELMO1 gene with DN occurred at rs741301 [odds ratio (OR) 1.89; p=0.004] and rs10951509 (OR 1.76; p=0.02). Unconditional logistic regression analysis identified that the rs741301 polymorphism (presence of A allele, adjusted OR 3.27; p=0.03) and duration of T2DM (adjusted OR 1.15; p=0.04) were independent predictors for DN. The marker rs741301 located in intron 18 of ELMO1 gene was in strong linkage disequilibrium (LD) with rs11769038 (D'=0.91). Furthermore, haplotype analysis identified that haplotype 1 [CAAAGA] (OR 1.95; p=0.01), haplotype 2 [CAAAGG] (OR 0.50; p=0.01), and haplotype 9 [TGCGGG] (OR 0.17; p=0.007) of ELMO1 were significantly associated with DN. CONCLUSIONS: This study first investigated the association of ELMO1 gene polymorphisms with DN in a Chinese population, supporting its key role as a candidate gene in the susceptibility of DN.
BACKGROUND: Genetic variations in the engulfment and cell motility 1 (ELMO1) gene have recently been identified to be associated with nephropathy attributed to Type 2 diabetes mellitus (T2DM). Since T2DM-associated complications are proved to be more common among Asians than Western individuals, and Chinese people have a high incidence of diabetic nephropathy (DN), this study sought to analyze the association of ELMO1 gene polymorphisms with DN to probe into the effects of ELMO1 gene on susceptibility of DN in Chinese population. METHODS: We genotyped 6 polymorphism sites of ELMO1 gene in 200 unrelated Chinese subjects (123 T2DM with DN case subjects and 77 T2DM without DN control subjects). Genotyping was detected by a Sequenom MassARRAY genotyping system. RESULTS: The strongest associations in ELMO1 gene with DN occurred at rs741301 [odds ratio (OR) 1.89; p=0.004] and rs10951509 (OR 1.76; p=0.02). Unconditional logistic regression analysis identified that the rs741301 polymorphism (presence of A allele, adjusted OR 3.27; p=0.03) and duration of T2DM (adjusted OR 1.15; p=0.04) were independent predictors for DN. The marker rs741301 located in intron 18 of ELMO1 gene was in strong linkage disequilibrium (LD) with rs11769038 (D'=0.91). Furthermore, haplotype analysis identified that haplotype 1 [CAAAGA] (OR 1.95; p=0.01), haplotype 2 [CAAAGG] (OR 0.50; p=0.01), and haplotype 9 [TGCGGG] (OR 0.17; p=0.007) of ELMO1 were significantly associated with DN. CONCLUSIONS: This study first investigated the association of ELMO1 gene polymorphisms with DN in a Chinese population, supporting its key role as a candidate gene in the susceptibility of DN.
Authors: Sulgi Kim; Hanna E Abboud; Madeleine V Pahl; John Tayek; Susan Snyder; James Tamkin; Harry Alcorn; Eli Ipp; Cynthia C Nast; Robert C Elston; Sudha K Iyengar; Sharon G Adler Journal: Clin J Am Soc Nephrol Date: 2010-03-18 Impact factor: 8.237
Authors: A Shimazaki; Y Tanaka; T Shinosaki; M Ikeda; H Watada; T Hirose; R Kawamori; S Maeda Journal: Kidney Int Date: 2006-10-04 Impact factor: 10.612
Authors: T L Gumienny; E Brugnera; A C Tosello-Trampont; J M Kinchen; L B Haney; K Nishiwaki; S F Walk; M E Nemergut; I G Macara; R Francis; T Schedl; Y Qin; L Van Aelst; M O Hengartner; K S Ravichandran Journal: Cell Date: 2001-10-05 Impact factor: 41.582
Authors: Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh Journal: Exp Biol Med (Maywood) Date: 2008-01
Authors: A L Mooyaart; E J J Valk; L A van Es; J A Bruijn; E de Heer; B I Freedman; O M Dekkers; H J Baelde Journal: Diabetologia Date: 2010-12-03 Impact factor: 10.122
Authors: Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski Journal: Diabetes Date: 2009-08-03 Impact factor: 9.461
Authors: A Turki; S Mzoughi; N Mtitaoui; M Khairallah; H Marmouch; S Hammami; T Mahjoub; W Y Almawi Journal: J Endocrinol Invest Date: 2017-07-27 Impact factor: 4.256
Authors: Catherine K Hathaway; Albert S Chang; Ruriko Grant; Hyung-Suk Kim; Victoria J Madden; C Robert Bagnell; J Charles Jennette; Oliver Smithies; Masao Kakoki Journal: Proc Natl Acad Sci U S A Date: 2016-02-08 Impact factor: 11.205
Authors: Masao Kakoki; Edward M Bahnson; John R Hagaman; Robin M Siletzky; Ruriko Grant; Yukako Kayashima; Feng Li; Esther Y Lee; Michelle T Sun; Joan M Taylor; Jessica C Rice; Michael F Almeida; Ben A Bahr; J Charles Jennette; Oliver Smithies; Nobuyo Maeda-Smithies Journal: JCI Insight Date: 2019-06-20